Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Yong Li

Director

Children's Mercy Hospital

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Professor Yong Li is a faculty member at Baylor College of Medicine in the United States. His research focuses on the tumor microenvironment, immune cell interactions, and the development of cancer immunotherapies, as evidenced by his recent publications. Notable areas of exploration include the progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma, and the utility of DNA vaccines in targeting specific cancer mutations. Professor Li's work aims to enhance patient stratification and therapeutic outcomes in hematological malignancies.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Yanhong Liu

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Karen Dybkaer

Aalborg University

DENMARK

View details

Govind Bhagat

Professor and Chair

Saint Louis University School of Medicine

UNITED STATES

View details

Ken H. Young

Professor

Duke University Medical Center

UNITED STATES

View details

Ali Sakhdari

Assistant Proferssor

University Health Network

CANADA

View details

Fenghuang Zhan

Professor, Morrison Family Endowed Chair

University of Arkansas for Medical Sciences

UNITED STATES

View details

Michael Boe Møller

Odense Universitetshospital

DENMARK

View details

Chao Cheng

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Alexandar Tzankov

Head Histopathology and Autopsy

University Hospital Basel

SWITZERLAND

View details

DANIELE GENERALI

University of Trieste

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yong Li

Research Interests

Make your next move.

Explore related searches

About

Articles (21)

Spatial Proximity of Immune Cell Pairs to Cancer Cells in the Tumor Microenvironment as Biomarkers for Patient Stratification

Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma

Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation

Vaccines targeting p53 mutants elicit anti-tumor immunity

Expanding nucleic acid-encoded medicine

DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma

Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing

Correction: Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma

DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma

Expanding anti-CD38 immunotherapy for lymphoid malignancies

Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave

Cancer/testis antigens: from serology to mRNA cancer vaccine

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

MYC activity inference captures diverse mechanisms of aberrant MYC pathway activation in human cancers.

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.

Collaborators (10)

Yanhong Liu

Karen Dybkaer

Govind Bhagat

Ken H. Young

Ali Sakhdari

Fenghuang Zhan

Michael Boe Møller

Chao Cheng

Alexandar Tzankov

DANIELE GENERALI

Make your next move.